Case study

A Year In, 22% Behind. Back on Track in Under 90 Days.

A mid-sized biopharma brought ProofPilot a Phase II solid-tumor oncology trial running 22% behind plan at month 14 of a 24-month window. The Enrollment Optimizer diagnosed cohort drift, triaged site performance, and modelled a recovery path that the sponsor executed in one steering cycle.

Enrollment Optimizer

Get the full case study

Free PDF. Straight to your inbox.

The results

-11 mos

Faster projected completion

-37%

Screen-failed rate

+8 sites

Capacity added

+41 pts

Odds of completion

Inside the case study

01

The challenge

ProofPilot identified the root causes behind declining enrollment, rising screen-fail rates, and underperforming countries.
02

The approach

Live trial data was used to model recovery scenarios and determine the fastest path back to target.
03

The outcome

The sponsor increased projected completion odds from 48% to 89%, improved screening performance, and restored enrollment velocity within 12 weeks.

See how they did it

The full case study, straight to your inbox. Nothing beyond your email address.

Get the case study